kalshi Science and Technology

When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?

Before October 2027
Closes Oct 01, 2027 (433d) 24h volume 67 Open interest 623 Event When will the FDA approve Intellia Therapeutics' lonvo-z?
55%
implied YES probability
+1.0pp 24h

Price history

Last 18 days · High 54% · Low 40% · 7d +4.0pp
54%40%

Other outcomes in this event

Related stocks

Trade on Kalshi

Open on Kalshi
Frenzy Capital does not execute trades on prediction markets — we aggregate public order-book and trading data for analysis.

Prediction market data reflects speculative event probabilities, not guaranteed outcomes. This is not investment advice. See Terms §17.